GlucoTrack, Inc. (GCTK) Stock Ticker
GCTK right now
Market factors today
Unlock the full GCTK picture
About GlucoTrack, Inc.
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
GCTK stock facts
| Ticker symbol | GCTK |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Market cap | $1.5M |
| CEO | Erik Emerson |
| Employees | 15 |
| Headquarters | Rutherford, NJ, US |
| IPO date | 2013-04-25 |
| Website | www.glucotrack.com |
What you can see for GCTK on Tickr
Live GCTK price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the GCTK report.
Rankings
FAQ
What is the ticker symbol for GlucoTrack, Inc.?
The ticker symbol for GlucoTrack, Inc. is GCTK, listed on the NASDAQ Capital Market.
What is GCTK?
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.